Ignite Creation Date:
2025-12-24 @ 4:07 PM
Ignite Modification Date:
2025-12-24 @ 4:07 PM
Study NCT ID:
NCT04005066
Status:
COMPLETED
Last Update Posted:
2022-12-19
First Post:
2019-04-18
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase IV Study of Elunate® (Fruquintinib) in Chinese Patients
Sponsor:
Hutchmed
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-04-20
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-27
Completion Date Type:
ACTUAL
First Submit Date:
2019-04-18
First Submit QC Date:
None
Study First Post Date:
2019-07-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-15
Last Update Post Date:
2022-12-19
Last Update Post Date Type:
ACTUAL